Proteona Pte.
Latest round
- Seed
Last raised
- Jan 2020
Total raised
- $3.1M
Investors
- 3
About Proteona Pte.
Based in Singapore, and established in 2017, Proteona Pte., is a biomedical company that provides single-cell analysis services for its customers. The company is a result of a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology, and Research (A*STAR)., Ltd. acquired the firm. As of April 2022, Proteona Pte. Ltd. The company offers clinical sample analysis services through its proprietary platform called ESCAPE™ (enhanced single-cell analysis with protein expression), enabling pharmaceutical firms, clinicians, etc to add single-cell level precision to their projects, and thereby enhance the clinical outcomes. The firm’s platform generates both genomic and proteomic data from a single cell, identifies various biomarkers, and creates ML (Machine Learning) based models that predict therapeutic response and disease severity. Additionally, Proteona Pte. Ltd. provides AI (Artificial Intelligence) and bioinformatics-powered single-cell data analysis for its customers.
Who invested in Proteona Pte.
3 investors across 1 round
See all investors in Proteona Pte.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 23, 2020
Amount
$3.1M
Investors
Questions about Proteona Pte.
Who invested in Proteona Pte.?
Proteona Pte. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proteona Pte. raised?
Proteona Pte. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Proteona Pte. last raise money?
Proteona Pte.'s most recent round on record is a Seed, in Jan 2020.
What does Proteona Pte. do?
Based in Singapore, and established in 2017, Proteona Pte.
Where is Proteona Pte. headquartered?
Proteona Pte. is headquartered in Singapore.
Which VCs invest in companies like Proteona Pte.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Proteona Pte.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Proteona Pte.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.